ABT vs LESL · P/E 25, rev $44.33B vs rev $790.4M
Abbott Laboratories (ABT) versus Leslies Inc (LESL) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Leslies Inc (LESL) is a specialty retail company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported LESL revenue for 2026-07-04 was $790.4M. Net income was -$87.7M. LESL currently screens at market cap $71.9M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. LESL currently screens at market cap $71.9M.
Not investment advice. Open the ABT and LESL stock pages for the full models.
Not investment advice.